Signos is the first FDA-cleared metabolic health platform that utilizes continuous glucose monitoring (CGM) to help users understand and improve their metabolism in real-time. By providing personalized, actionable recommendations based on glucose data, Signos supports sustainable weight management and better metabolic health.

Signos is the first FDA-cleared metabolic health platform that utilizes continuous glucose monitoring (CGM) to help users understand and improve their metabolism in real-time. By providing personalized, actionable recommendations based on glucose data, Signos supports sustainable weight management and better metabolic health.